Search results for "stroke."

showing 10 items of 1178 documents

Effect of ischaemic preconditioning, cardiopulmonary bypass and myocardial ischaemic/reperfusion on free radical generation in CABG patients.

2001

Abstract Objective: To investigate the free radicals (FR) generation after ischaemic preconditioning and cardiopulmonary bypass and during reperfusion in CABG patients, and the role of ischaemic preconditioning. Methods: Forty-three CABG patients were randomised into an ischaemic preconditioning and a control group. The protocol for ischaemic preconditioning was two cycles of 2-min ischaemia followed by 3-min reperfusion. Free radicals were measured using electron spin resonance spectroscopy. Global and right heart functions were collected. Results: The free radicals generation in coronary sinus blood in the ischaemic preconditioning group was 9.7 and 16.6% after the ischaemic preconditioni…

Malemedicine.medical_specialtyFree RadicalsIschemiaCardiac indexMyocardial IschemiaHemodynamicsVentricular Function Leftlaw.inventionRight ventricular ejection fractionPostoperative ComplicationslawInternal medicineCardiopulmonary bypassmedicineHumansRadiology Nuclear Medicine and imagingCardiac OutputCoronary Artery BypassCoronary sinusAgedMyocardial StunningCardiopulmonary Bypassbusiness.industryStunningHemodynamicsStroke VolumeMiddle Agedmedicine.diseaseAnesthesiaIschemic Preconditioning MyocardialCardiologyIschemic preconditioningSurgeryFemaleCardiology and Cardiovascular MedicinebusinessCardiovascular surgery (London, England)
researchProduct

Gelatinases and their tissue inhibitors in a group of subjects with obstructive sleep apnea syndrome.

2016

Obstructive sleep apnea syndrome (OSAS) is associated with an elevated risk of cardiovascular events and stroke. Matrix metalloproteinases (MMPs) are endopeptidases involved in extracellular matrix degradation and then in the development and progression of cardiovascular diseases. Our aim was to evaluate plasma levels of gelatinases (MMP-2 and MMP-9) and their tissue inhibitors (TIMP-1 and TIMP-2) in a group of subjects with OSAS. We enrolled 48 subjects (36 men and 12 women; mean age 49.7 ± 14.68 yrs) with OSAS diagnosed with a 1-night cardiorespiratory study and then we subdivided these subjects into two subgroups according to the apnea/hypopnea index (AHI): Low (L = 21 subjects with AHI …

Malemedicine.medical_specialtyGelatinasesSettore MED/09 - Medicina InternaPhysiologyMMP-2; MMP-9; obstructive sleep apnea; TIMP-1; TIMP-2; Disease Progression; Female; Gelatinases; Humans; Male; Middle Aged; Sleep Apnea Obstructive; Tissue Inhibitor of Metalloproteinase-1; Physiology; Hematology; Cardiology and Cardiovascular Medicine; Physiology (medical)030204 cardiovascular system & hematologyMatrix metalloproteinaseGastroenterologyTIMP-203 medical and health sciencesTIMP-10302 clinical medicinePhysiology (medical)Internal medicinemedicineHumansStrokeobstructive sleep apneaOxygen saturation (medicine)Sleep Apnea ObstructiveTissue Inhibitor of Metalloproteinase-1MMP-2business.industryApneaCardiorespiratory fitnessHematologyMiddle Agedmedicine.diseasenervous system diseasesrespiratory tract diseasesObstructive sleep apneaEndocrinology030228 respiratory systemGelatinaseGelatinasesDisease ProgressionFemalemedicine.symptomMMP-9Settore MED/36 - Diagnostica Per Immagini E RadioterapiaCardiology and Cardiovascular MedicinebusinessHypopneaHumanClinical hemorheology and microcirculation
researchProduct

Protective effect of homovanillyl alcohol on cardiovascular disease and total mortality: virgin olive oil, wine, and catechol-methylathion

2016

Background: Hydroxytyrosol is a phenolic compound that is present in virgin olive oil (VOO) and wine. Hydroxytyrosol-related foods have been shown to protect against cardiovascular disease (CVD).Objective: We investigated the associations between hydroxytyrosol and its biological metabolite, 3-O-methyl-hydroxytyrosol, also known as homovanillyl alcohol (HVAL), with CVD and total mortality.Design: We included 1851 men and women with a mean ± SD age of 66.8 ± 6 y at high risk of CVD from prospective cohort data. The primary endpoint was a composite of myocardial infarction, stroke, and death from cardiovascular causes; the secondary endpoint was all-cause mortality. Twenty-four-hour urinary h…

Malemedicine.medical_specialtyGenotypeMediterranean dietCatecholsMyocardial InfarctionMedicine (miscellaneous)Wine030204 cardiovascular system & hematologyCatechol O-MethyltransferaseLower riskMethylationGastroenterology03 medical and health scienceschemistry.chemical_compound0302 clinical medicinePhenolsCause of DeathInternal medicineHomovanillyl alcoholmedicineClinical endpointHumans030212 general & internal medicineProspective cohort studyOlive OilAgedNutrition and DieteticsCatechol-O-methyl transferasebusiness.industryHomovanillic AcidMiddle AgedPhenylethyl AlcoholDietStrokechemistryCardiovascular DiseasesHydroxytyrosolFemalebusinessBiomarkersrs4680The American Journal of Clinical Nutrition
researchProduct

Clinical Benefit of Cardiac Resynchronization Therapy With a Defibrillator in Patients With an Ejection Fraction > 35% Estimated by Cardiac Magnet…

2014

A B S T R A C T Introduction and objectives: Cardiac resynchronization therapy with a defibrillator prolongs survival and improves quality of life in advanced heart failure. Traditionally, patients with ejection fraction > 35 estimated by echocardiography have been excluded. We assessed the prognostic impact of this therapy in a group of patients with severely depressed systolic function as assessed by echocardiography but with an ejection fraction > 35% as assessed by cardiac magnetic resonance. Methods: We analyzed consecutive patients admitted for decompensated heart failure between 2004 and 2011. The patients were in functional class II-IV, with a QRS to 120 ms, ejection fraction 35% es…

Malemedicine.medical_specialtyHeart Ventriclesmedicine.medical_treatmentCardiac resynchronization therapyMagnetic Resonance Imaging CineCardiac Resynchronization TherapyNecrosisQRS complexQuality of lifeInternal medicinemedicineHumansAgedHeart FailureEjection fractionmedicine.diagnostic_testbusiness.industryMyocardiumStroke VolumeMagnetic resonance imagingGeneral Medicinemedicine.diseaseImplantable cardioverter-defibrillatorDefibrillators ImplantableHeart failureVentricular FibrillationTachycardia VentricularCardiologyFemalebusinessCardiac magnetic resonanceRevista Española de Cardiología (English Edition)
researchProduct

Functional Mitral Regurgitation Predicts Short-Term Adverse Events in Patients With Acute Heart Failure and Reduced Left Ventricular Ejection Fraction

2017

Functional mitral regurgitation (FMR) is a common finding in patients with acute heart failure (AHF) and reduced left ventricular ejection fraction (heart failure and reduced ejection fraction [HFrEF]). However, its clinical impact remains unclear. We aimed to evaluate the association between the severity of FMR after clinical stabilization and short-term adverse outcomes after a hospitalization for AHF. We prospectively included 938 consecutive patients with HFrEF discharged after a hospitalization for AHF, after excluding those with organic valve disease, congenital heart disease, or aortic valve disease. FMR was assessed semiquantitatively by color Doppler analysis of the regurgitant jet…

Malemedicine.medical_specialtyHeart diseaseHeart Ventricles030204 cardiovascular system & hematologyVentricular Function LeftElectrocardiography03 medical and health sciences0302 clinical medicineInternal medicinemedicineClinical endpointHumansIn patientProspective Studies030212 general & internal medicineAdverse effectProspective cohort studyAgedHeart FailureEjection fractionmedicine.diagnostic_testbusiness.industryMitral Valve InsufficiencyStroke VolumePrognosismedicine.diseaseEchocardiography DopplerSurvival RateSpainHeart failureAcute DiseaseCardiologyFemaleCardiology and Cardiovascular MedicinebusinessElectrocardiographyFollow-Up StudiesThe American Journal of Cardiology
researchProduct

Immuno-inflammatory predictors of stroke at follow-up in patients with chronic non-valvular atrial fibrillation (NVAF).

2009

Accumulating evidence suggests that inflammation plays an important role in the acute phase of ischemic stroke. CD40 L is a well recognized atherosclerotic inflammatory marker, whereas recent evidence suggests a pro-inflammatory role of Fetuin-A. To analyze the role of an inflammatory marker such as CD40 L and of a candidate pro-inflammatory marker such as Fetuin-A in acute stroke we evaluated their serum levels in subjects with acute ischemic stroke and their possible association with other laboratory and clinical variables. MATERIALS AND METHODS: We enrolled 107 consecutive patients with a diagnosis of acute ischemic stroke admitted to the Internal Medicine Department at the University of…

Malemedicine.medical_specialtyHeart diseaseImmuno-inflammatory predictorCentral nervous system diseaseVon Willebrand factorpatients with chronic non-valvular atrial fibrillationInternal medicineAtrial FibrillationMedicineHumansInterleukin 6StrokeAgedbiologyReceiver operating characteristicbusiness.industryVascular diseaseAtrial fibrillationGeneral MedicineMiddle Agedmedicine.diseasePrognosisSurgeryStrokeChronic Diseasebiology.proteinCardiologypredictors of strokeFemalebusinessEpidemiologic MethodsBiomarkers
researchProduct

Inflammatory pathways in patients with heart failure and preserved ejection fraction.

2008

Immune activation is well established in patients with chronic heart failure and reduced ejection fraction (HF and reduced EF) and is associated with an impaired prognosis. Patients with heart failure and preserved ejection fraction (HF and preserved EF) have an impaired prognosis as well. It is not known whether they have signs of immune activation.We studied patients with HF and preserved EF (n=17, NYHA II [n=7]/III [n=10]) and patients with HF and reduced EF (n=17 NYHA II [n=1]/III [n=16]) and 20 controls. Echocardiography demonstrated preserved ejection fraction (LVEF 59+/-9%), but LV hypertrophy in patients with preserved EF as compared with patients with reduced EF (LVEF 23+/-5%). We …

Malemedicine.medical_specialtyHeart diseasemedicine.medical_treatmentHemodynamicsInflammationVentricular Function LeftInternal medicineNatriuretic Peptide BrainmedicineHumansIn patientReceptorAgedAged 80 and overHeart FailureInflammationEjection fractionbusiness.industryStroke VolumeMiddle Agedmedicine.diseasePeptide FragmentsCytokineHeart failureCardiologyCytokinesFemalemedicine.symptomInflammation MediatorsCardiology and Cardiovascular MedicinebusinessSignal TransductionInternational journal of cardiology
researchProduct

Use of rivaroxaban for the prevention of stroke in patients with nonvalvular atrial fibrillation in Spain

2018

Aim: To analyze the clinical profile and rates of stroke, major bleeding and intracranial hemorrhage of patients with atrial fibrillation (AF) treated with rivaroxaban in clinical practice. Methods: Retrospective study of AF patients anticoagulated with rivaroxaban in a Healthcare Area of Valencia, Spain. Patients started treatment with rivaroxaban from July 2012 to December 2015. Results: A total of 230 patients (mean age 76.9 ± 9.9 years; CHA2DS2-VASc 4.3 ± 1.7; HAS-BLED 1.7 ± 0.9) were included. Rates of stroke, major bleeding and intracranial bleeding were 0.4, 1.9 and 0.5 events per 100 patient-years, respectively. Conclusion: In this cohort of AF patients anticoagulated with rivaroxa…

Malemedicine.medical_specialtyHemorrhage030204 cardiovascular system & hematology03 medical and health sciences0302 clinical medicineRivaroxabanRisk FactorsInternal medicineAtrial FibrillationmedicineHumansIn patient030212 general & internal medicinePractice Patterns Physicians'StrokeAgedRetrospective StudiesAged 80 and overRivaroxabanbusiness.industryRetrospective cohort studyMean ageAtrial fibrillationmedicine.diseaseStrokeSpainCohortMolecular MedicineFemaleCardiology and Cardiovascular MedicinebusinessMajor bleedingFactor Xa Inhibitorsmedicine.drugFuture Cardiology
researchProduct

Endovascular Treatment of Spontaneous Internal Carotid Artery Dissection with Proximal Embolic Protection Device

2019

Background The aim of this study was to report the feasibility and outcomes with the endovascular treatment of spontaneous internal carotid artery dissections (ICADs) using a proximal embolic protection device (EPD). Methods This is a retrospective analysis of patients treated for spontaneous symptomatic ICAD using a proximal EPD from January 2017 to December 2018. Indication for treatment was the presence of neurologic symptoms. Early outcomes measured included technical success, perioperative mortality, and major cardiovascular or cerebrovascular complications. Late outcomes were recurrent neurologic symptoms, patency, and reinterventions. Results A total of 4 male patients with ICAD were…

Malemedicine.medical_specialtyICADAmaurosis FugaxCarotid Artery Internal Dissection030204 cardiovascular system & hematologySettore MED/22 - Chirurgia VascolareEmbolic Protection Devices030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicineproximal embolic protection deviceRestenosisinternal carotid artery dissectionmedicine.arteryAphasiamedicineHumansCarotid StenosisStrokeRetrospective StudiesInternal carotid artery dissectioncarotid artery stentingbusiness.industryEndovascular ProceduresGeneral MedicineAmaurosis fugaxPerioperativeMiddle Agedmedicine.diseaseSurgeryStenosisTreatment OutcomeIschemic Attack TransientendovascularStentsSurgeryInternal carotid arterymedicine.symptomCardiology and Cardiovascular MedicinebusinessCarotid Artery Internal
researchProduct

Glutathione Peroxidase-1 Activity, Atherosclerotic Burden, and Cardiovascular Prognosis

2007

Recent findings suggest that erythrocyte intracellular glutathione peroxidase-1 (GPX-1) activity is related inversely to future cardiovascular events. The aim of this study is to evaluate the association of GPX-1 activity to extent of atherosclerosis, as well as its long-term prognosis in context with atherosclerotic burden. In a prospective study, we included 508 patients before coronary angiography. Atherosclerosis of carotid and leg arteries was documented using sonographic methods. Blood samples were drawn after an overnight fasting period, and GPX-1 activity was determined in washed erythrocytes. GPX-1 activity tended to decrease with increasing numbers of atherosclerotic vascular beds…

Malemedicine.medical_specialtyInfarctionContext (language use)Coronary Artery DiseaseCoronary AngiographySensitivity and SpecificitySeverity of Illness IndexDisease-Free SurvivalGlutathione Peroxidase GPX1Predictive Value of TestsGermanyInternal medicinemedicineHumansProspective StudiesProspective cohort studyStrokeAgedchemistry.chemical_classificationGlutathione PeroxidaseVascular diseasebusiness.industryGlutathione peroxidaseHazard ratioMiddle Agedmedicine.diseasechemistryCirculatory systemCardiologyFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersThe American Journal of Cardiology
researchProduct